Ads
related to: beta thalassemia major complications- ZYNTEGLO™ Safety Info
Review Safety & Side Effect
Information That May Impact You.
- ZYNTEGLO™ Resources
See FAQs & Prompts To Help You Have
A Conversation With Your Doctor.
- Treatment With ZYNTEGLO™
Review The Timeline & Steps For
Treatment With ZYNTEGLO.
- Receive ZYNTEGLO™ Updates
Sign Up To Receive Emails With
Additional ZYNTEGLO Resources.
- FDA Approved ZYNTEGLO™
Learn About This Treatment Option
That You May Be Eligible For.
- ZYNTEGLO™ FAQs
Find Answers To Commonly Asked
Questions About ZYNTEGLO.
- ZYNTEGLO™ Safety Info
Search results
Results From The WOW.Com Content Network
Beta thalassemia minor can also present as beta thalassemia silent carriers; those who inherit a beta thalassemic mutation but have no hematologic abnormalities nor symptoms. [8] Some people with thalassemia are susceptible to health complications that involve the spleen (hypersplenism) and gallstones (due to hyperbilirubinemia from peripheral ...
TDTs include beta-thalassemia major, hemoglobin H disease, and severe HbE/beta-thalassemia. NTDT does not need regular transfusions but may require transfusion in case of an anemia crisis. [9] Complications of transfusion include iron overload with resulting heart or liver disease. [1]
Mild thalassemia : patients with thalassemia traits do not require medical or follow-up care after the initial diagnosis is made. [2] Patients with β-thalassemia trait should be warned that their condition can be misdiagnosed for the common Iron deficiency anemia.
Hemoglobin E/ beta thalassemia: common in Cambodia, Thailand, and parts of India, it is clinically similar to β thalassemia major or β thalassemia intermedia. [34] Hemoglobin S/ beta thalassemia: common in African and Mediterranean populations, it is clinically similar to sickle-cell anemia. [35] Delta-beta thalassemia is a rare form of ...
Beta-thalassemia is a genetic disease mostly caused by beta-globin gene mutations. [18] Clinical diagnosis is based on interpretation of the peripheral blood smear, which examines red blood cell morphology, followed by hemoglobin analysis and confirmed by DNA sequencing.
Splenic sequestration crisis is a life-threatening illness common in pediatric patients with homozygous sickle cell disease and beta thalassemia.Up to 30% of these children may develop splenic sequestration crisis with a mortality rate of up to 15%.
Beta-thalassemia: D56.1: 3087: Beta-thalassemia (β-thalassemia) is an autosomal dominant blood condition that results in the reduction of hemoglobin production. The cause for the disorder is related to a genetic mutation of the HBB gene. This gene is responsible for providing the instructions to produce beta-globin; one of the major components ...
Hemoglobinopathies (congenital abnormality of the hemoglobin molecule or of the rate of hemoglobin synthesis) . Sickle cell disease; Thalassemia; Methemoglobinemia; Anemias (lack of red blood cells or hemoglobin)